Substituted imidazopyridines as potent inhibitors of HCV replication

Inge Vliegen; Jan Paeshuyse; Tine De Burghgraeve; Laura S. Lehman; Matthew Paulson; I‐hung Shih; Eric Mabery; Nina Böddeker; De Clercq Erik; Hans Reiser; David Oare; William A. Lee; Weidong Zhong; Steven Bondy; Gerhard Pürstinger; Johan Neyts

doi:10.1016/j.jhep.2008.12.028

Related publications

Article2007

The substituted imidazopyridine GS-327073 is a potent inhibitor of HCV replication

Inge Vliegen, Jan Paeshuyse, Weidong Zhong, Laura S. Lehman, Sofie Roofthooft, Hélène Dutartre, Barbara Selisko, Bruno Canard, Steven Bondy, David Oare, De Clercq Erik, William A. Lee, Gerhard Pürstinger, Johan Neyts

Article2009

Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors

Dustin L. McMinn, Yosup Rew, Athena Sudom, Seb Caille, Michael DeGraffenreid, Xiaodong He, Randall W. Hungate, Ben Jiang, Juan C. Jaén, Lisa D. Julian, Jacob A. Kaizerman, Perry M. Novak, Daqing Sun, Hua Tu, Stefania Ursu, Nigel P.C. Walker, Xuelei Yan, Qiuping Ye, Zhong Lin Wang, Jay P. Powers

Article2006

Substituted imidazopyridines as potent inhibitors of HCV replication

Discussion(0)

Related publications

The substituted imidazopyridine GS-327073 is a potent inhibitor of HCV replication

Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors

Thiazolobenzimidazoles as potent inhibitors of the in vitro replication of Coxsackie B virus

Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles

The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication